Feedback / Questions
cirtuvivint (SM08502) - Biosplice Therap
Lynparza (olaparib) - Merck (MSD), AstraZeneca
https://www.manilatimes.net/2025/12/22/tmt-newswire/globenewswire/biosplice-therapeutics-announces-first-patient-dosed-in-investigatorinitiated-phase-1-clinical-trial-of-cirtuvivint-and-olaparib-in-brcahrd-platinumresistant-ovarian-cancer/2247902
Dec 22, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next